Compared to nerve stimulation or classic paraesthesia techniques, ultrasound (US)-guided popliteal sciatic nerve block requires a smaller volume of local anaesthetic. The up-and-down method was used to determine the minimum effective anaesthetic volume of 0.5% ropivacaine necessary for US-guided popliteal sciatic nerve block to achieve successful surgical anaesthesia for foot and ankle surgery. The study included 32 patients receiving an US-guided popliteal sciatic nerve bock. The starting dose of 0.5% ropivacaine was set at 30 ml, which was decreased by 3 ml if the block succeeded and increased by 3 ml if the block failed. After the injection of local anaesthetic, the degree of sensory and motor blockade of the tibial and common peroneal nerves was assessed every 5 minutes for 30 minutes. The ED 50 and ED 95 volumes of local anaesthetic were 6 ml and 16 ml, respectively. The success rates of sensory blockade of the tibial nerve and common peroneal nerve were 69% and 88%, respectively. The success rates of motor blockade of these nerves were 75% and 90%, respectively. The ED 50 and ED 95 of 0.5% ropivacaine for US-guided popliteal sciatic nerve block were 6 ml and 16 ml, respectively.
Compared to nerve stimulation or classic paraesthesia techniques, ultrasound (US)-guided peripheral nerve blocks have major advantages of needle placement at the desired place, real-time verification of local anaesthetic (LA) distribution, short procedural time, lower volume of LA required for a successful block and a decreased incidence of complications and side-effects [1] [2] [3] .
Often, large volumes of LA are used for peripheral nerve blocks to ensure successful surgical anaesthesia 4, 5 . However, US-guided peripheral nerve blocks allow visual verification of the relationship between the peripheral nerve and LA, thereby enabling blocks to be performed with a smaller total volume of LA [6] [7] [8] .
Estimates of the minimal effective anaesthetic volume (MEAV) required for US-guided peripheral nerve blocks were recently published 2, 9, 10 . US guidance was associated with a 42% reduction in the MEAV of 0.5% ropivacaine required to block the femoral nerve, compared to the volume required when using nerve stimulator guidance 2 . The MEAV for sciatic nerve block using nerve stimulator guidance was previously evaluated by Taboada et al 11 , and Latzke et al 10 evaluated the MEAV of US-guided sciatic nerve block performed at the mid-femoral level in volunteers. The primary objective of this study is to estimate the volume of 0.5% ropivacaine necessary to block the sciatic nerve at the popliteal injection site under US guidance.
Methods
The study protocol was approved by the Hanyang University Hospital Institutional Review Board (HYUH 2012-11-028-002) and written informed consent was obtained from all patients enrolled in the study. This study was registered at the Clinical Research Information Service (http://cris.nih.go.kr/ cris/ [KCT0000648]). It was conducted from January 2013 to June 2013. Thirty-two patients scheduled for foot and ankle surgery, who had an American Society of Anesthesiologists Physical Status of 1 or 2 and an age between 18 and 75 years, were enrolled in this study. Patients were excluded from the study if they were younger than 18 or had a significant coagulopathy, infection at the injection site, allergy to LA, severe cardiopulmonary disease or known neuropathy.
Ropivacaine 0.5% was administered for sciatic nerve block using Dixon's up-and-down method 10, 12, 13 . The starting dose of LA was set at 30 ml of 0.5% ropivacaine, based on the ED 95 obtained with another type of LA by Taboada et al 11 . We used the up-and-down method, in which the previous patient's block outcome was used to determine the next patient's LA volume. If the block failed, the next patient's volume was increased by 3 ml (10% of the initial volume) and if the block was successful, the volume was decreased by 3 ml.
All sciatic nerve blocks were performed by a single anaesthetist, who had substantial expertise in US-guided peripheral nerve blocks. In the waiting area prior to surgery, all patients received intramuscular midazolam 0.05 mg/kg and intravenous access was established. Upon arrival in the operating room, standard monitoring was initiated, including continuous electrocardiography and pulse oximetry and non-invasive arterial blood pressure. The patient was positioned in the prone position and a pillow was placed under his or her ankle. The needle insertion site was prepared with antiseptic, followed by the creation of a skin wheal at the insertion site using 2 ml of 1% lignocaine. Portable US equipment (SonoSite Micromaxx, SonoSite Inc., Bothwell, WA, USA) with a 38 mm 6 to 13 MHz linear array transducer was used. A 'traceback' approach was used to locate the sciatic nerve at the bifurcation of the tibial and common peroneal nerves 14 . After verifying the identity of the sciatic nerve, an image of the nerve was maintained in the centre of the monitor and an in-plane technique from the lateral aspect of the leg was performed, using a 100 mm, 22-gauge insulated needle (Pajunk, Geisingen, Germany). When the needle was 1 to 2 mm outside the sciatic nerve, nerve stimulation with a Stimuplex HNS 11 nerve stimulator (B.Braun Medical, Bethlehem, PA, USA) was initiated, starting at a pulse duration of 0.1 ms, frequency of 2 Hz and current intensity of 1 mA. The goal was to identify the point at which a motor response (plantar flexion and/or inversion) was observed at a current intensity of less than 0.5 mA. The needle was positioned at the mid-point of the sciatic nerve bifurcation and, if no blood was obtained upon aspiration, the previously determined volume of 0.5% ropivacaine was injected. An additional 10 ml of 0.5% ropiv-acaine was infiltrated at the medial side of the ankle to block the saphenous nerve. To determine whether LA was injected intraneurally, the nerve diameter was measured before and after injection. It was planned that the case would be excluded from the study if intraneural injection was suspected by changes in nerve diameter; however, this was not necessary because suspected intraneural injection was not observed.
To assess the degree of blockade, an observer blinded to the procedure measured the degree of sensory and motor blockade in the tibial nerve and common peroneal nerve distribution at five-minute intervals for 30 minutes following LA injection. To measure sensory blockade, the pinprick test was used and the results were compared to those obtained in the contralateral limb. The tibial and common peroneal nerves were assessed at the plantar surface of the foot and dorsolateral aspect of the foot, respectively. For sensory testing, the grade of blockade was classified as follows: 0, complete sensory loss; 1, decreased sensation; 2, normal sensation. To evaluate the degree of motor blockade, the tibial and common peroneal nerves were assessed during plantar flexion of the foot and dorsiflexion of the foot, respectively. For motor testing, the grade of blockade was classified as follows: 0, no movement; 1, movement present but weaker than baseline; 2, normal movement. Successful surgical block was defined as a grade 0 sensory block and grade 0 motor block within 30 minutes, plus completion of the surgery without the need for general anaesthesia 11 . Block failure was defined as a sensory and/or motor block greater than 0 at 30 minutes or the need for general anaesthesia to complete the surgery. Surgery was performed under sciatic nerve block, as well as a propofol infusion to maintain light sedation, as indicated by a sluggish response to a light glabellar tap or loud auditory stimulus. The patients were followed for 48 hours after surgery for possible complications or side-effects.
Two study-stopping rules were used. Firstly, based on similar studies involving binary outcomes, we estimated that a minimum of ten independent, negative-positive up-and-down deflections was required to calculate the MEAV 9 . Secondly, it was agreed by consensus that reducing the dose below 3 ml was not of clinical importance. Therefore, ten consecutive patients with a successful US-guided popliteal sciatic nerve block were chosen as the second stopping point.
Statistical analysis
Summary statistics were performed using PASW18.0 for Windows (SPSS Inc., Chicago, IL, USA) and reported as the median and range. The data were analysed with isotonic regression to calculate the volume of 0.5% ropivacaine required to produce a successful sciatic nerve block within 30 minutes after LA injection in 50% (ED 50 ) and 95% (ED 95 ) of subjects. An adjusted response probability was calculated by the pooled adjacent-violators algorithm 15 . Tests of significance included the t-test for parametric variables and Mann-Whitney U test of ranks for nonparametric testing of 
Results
To assess the MEAV of 0.5% ropivacaine for popliteal sciatic nerve block, 32 patients were enrolled to acquire the ten individual negative-positive up-and-down deflections, which was the first study-stopping rule. Patient and surgical characteristics are shown in Table 1 . The volumes of LA used for each patient are shown in Figure 1 . According to Dixon's upand-down method, the MEAV of 0.5% ropivacaine required to block the sciatic nerve was 7 ml. The ED 50 and ED 95 were calculated using the isotonic regression estimator. The ED 50 and ED 95 volumes of LA were 6 ml and 16 ml, respectively.
Successful sensory block of the tibial nerve was achieved in 69% of subjects and successful sensory block of the common peroneal nerve was achieved in 88% of subjects (P=0.072). Successful sensory block at 20 and 25 minutes was significantly less frequent for the tibial nerve than for the common peroneal nerve (P=0.037 and P=0.040 at 20 and 25 minutes, respectively) ( Figure 2 ). Successful motor block in the tibial nerve distribution was achieved in 75% of subjects and successful common peroneal nerve motor block was achieved in 90% of subjects (P=0.102). None of the subjects enrolled in the study had complications or side-effects within 48 hours after surgery that were associated with the nerve block.
Discussion
In this study, the ED 50 and ED 95 volumes of 0.5% ropivacaine were 6 ml and 16 ml, respectively, for US-guided popliteal sciatic nerve block. These volumes were calculated using the isotonic regression estimator with Dixon's up-and-down method. The isotonic regression estimator method has less bias and greater precision than other up-and-down method estimators for calculating the ED 50 and ED 95 12 . The ED 50 and ED 95 volumes necessary to achieve sciatic nerve blockade using a nerve stimulator were previously reported to be 16 ml and 30 ml, respectively, for popliteal sciatic nerve block 11 . As the authors of that study used Dixon's up-and-down method to determine the ED 50 and logistic regression to determine the ED 95 , these results would translate into an ED 50 of 16 ml and an ED 95 of 26 ml using the isotonic regression method. These values are substantially higher than our results and we hypothesised that the discrepancy can be attributed to differing target localisation methods. This is in the context of reports of higher success rates for US-guided techniques compared to nerve stimulator techniques for posterior popliteal sciatic nerve blocks 3, 16 . There are various approaches for sciatic nerve blocks, including popliteal, subgluteal or mid-femoral approaches performed under US guidance 13, 17 . Among these approaches, the popliteal approach has three main advantages. Firstly, the depth of the nerve is relatively shallow at this site. Secondly, the sciatic nerve is easy to identify because the tibial nerve lies superficial and lateral to the popliteal artery, and thirdly, movement of the knee joint can be preserved, which may be beneficial for foot and ankle surgery 14, 18 .
Circumferential injection is advantageous for US-guided sciatic nerve block 19, 20 . In contrast to the multiple injections of LA used to achieve circumferential spreading 10 , we used a single-injection technique. We found that circumferential spreading around the sciatic nerve was achieved in all patients when more than 16 ml of LA was injected. It was hypothesised that the ED 50 and ED 95 could be decreased with the use of multiple injections. However, multiple injections for circumferential spreading of LA might cause patient discomfort and thus should be used with caution. The onset times of US-guided popliteal nerve blockade distal and proximal to the sciatic nerve bifurcation are 24 minutes and 34 minutes, respectively 21 . The onset times of nerve blockade for sub-epineural injections and targeted injections around the tibial and common peroneal nerves are 10.7 and 16.4 minutes, respectively 22 . Injection at the neural bifurcation should lead to a shorter onset time 22 . We injected LA just proximal to the tibial and common peroneal nerve bifurcation and obtained a block onset time of 17.4 minutes. We observed hypoechoic LA spreading distally alongside the division of the tibial and common peroneal nerve. It is possible that the block onset time was shortened in this study because the LA spread alongside the division of the nerves and the targeted injection was at the bifurcation. To increase the success rate and decrease the onset time of popliteal sciatic nerve blocks, we recommend that the injection be performed at the neural bifurcation.
In prior studies, the block evaluation time for sciatic nerve block has varied from 30 to 60 minutes 3, 10, 16, 19, 20 . Complete sensory and motor blockade of US-guided sciatic nerve block was previously reported in 100% of patients at 30 minutes 3, 16 . Therefore, we evaluated the block at 30 minutes in this study. However, in three of our patients, the degree of sensory and motor blockade was insufficient at 30 minutes, but 100% complete when re-evaluated at the end of surgery (these patients received 3, 6 and 12 ml of LA). It is, therefore, likely that by extending the time to evaluate a successful block beyond 30 minutes, the rate of successful surgical block would be increased and the ED 50 and ED 95 would be decreased.
Limitations
This study has limitations. One is that the rate of injection was not controlled. We tried to inject a constant volume over a constant duration to control the rate of injection. The duration of injection was certainly different for differing volumes, but the injection duration was not measured, so we are not sure that the speed of injection was constant. We cannot exclude the possibility that a relatively rapid injection is more pressurised than a slower injection and would produce more extensive spread of LA along the nerve. Another limitation of this study is the relatively high starting volume. Commonly, 20 to 30 ml of LA used for US-guided popliteal sciatic nerve blocks 3, 16, 19 . If we reduced the starting volume, the incremental change (10% of the starting volume) would also have been reduced. As a result, we would have required fewer than ten up-down swings to calculate the MEAV. Another limitation was that we did not limit the surgery to a specific type. Therefore, different surgical stimuli due to the varying types of surgery may have affected the MEAV.
Conclusion
In conclusion, this study determined the injection volume required for a popliteal sciatic nerve block. We found that the ED 50 and ED 95 were 6 and 16 ml, respectively, for an US-guided popliteal sciatic nerve block using 0.5% ropivacaine.
